Ruxolitinib (free base) ≥99% (durch HPLC)
Lieferant: Enzo Life Sciences
ALEXENZCHM1560010EA
364
EUR
ALEXENZCHM1560010
ALEXENZCHM1560005
Ruxolitinib (free base) ≥99% (durch HPLC)
Ruxolitinib (free base)
JAK inhibitor
Ruxolitinib is a Janus kinase inhibitor with IC50 values of 2.7 and 4.5, respectively, for JAK1 and JAK2.
Formel:
C₁₇H₁₈N₆ |
MDL Number:
MFCD12031592 CAS-Nummer: 941678-49-5 |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...